Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-15-008723
Filing Date
2015-11-17
Accepted
2015-11-17 08:44:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT a2226610z424b5.htm 424B5 424038
2 G191778.JPG g191778.jpg GRAPHIC 7061
  Complete submission text file 0001047469-15-008723.txt   435435
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207004 | Film No.: 151237099
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

EIN.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207004-02 | Film No.: 151237100
SIC: 2834 Pharmaceutical Preparations